Entrada Therapeutics (TRDA) Q1 2025 Earnings

27FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.73
0.03
0.79
1.55

Details

Expected EPS
-0.66975
Actual EPS
0.03
Surprise EPS
0.7
Surprise Percent
+104.48%

Description

Entrada Therapeutics (TRDA) has reported earnings of 0.03 per share for Q1 2025.

0 Comments

Share your thoughts